UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000027655
Receipt number R000031682
Scientific Title A phase II study of osimertinib in patients with poor performance status and EGFR mutation T790M-positive non-small-cell lung cancer
Date of disclosure of the study information 2017/06/07
Last modified on 2020/06/08 10:45:50

No. Disposal Last modified on Item of update
1 Insert 2017/06/06 11:44:39
2 Update 2020/06/08 10:41:07 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Organization
Organization
Division name
Division name
Zip code
Address
Address
Email
Organization
Organization
Address
Address
Tel
Email
3 Update 2020/06/08 10:45:12 Recruitment status
Date of IRB
Last follow-up date
4 Update 2020/06/08 10:45:50 Publication of results
Number of participants that the trial has enrolled